Bio-Rad Laboratories (NYSE:BIO.B) Share Price Passes Below 200 Day Moving Average of $311.79

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $311.79 and traded as low as $282.00. Bio-Rad Laboratories shares last traded at $283.45, with a volume of 2,005 shares trading hands.

Bio-Rad Laboratories Price Performance

The company has a 50 day moving average of $289.61 and a 200-day moving average of $311.67. The company has a debt-to-equity ratio of 0.13, a quick ratio of 4.89 and a current ratio of 6.57.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its earnings results on Tuesday, May 7th. The company reported $2.29 earnings per share (EPS) for the quarter. The business had revenue of $610.82 million during the quarter. Bio-Rad Laboratories had a negative net margin of 12.37% and a positive return on equity of 3.59%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.